tiprankstipranks
Gilead Sciences (GILD)
NASDAQ:GILD
US Market
GILD
Gilead Sciences
RESEARCH TOOLSreports
Want to see GILD full AI Analyst Report?

Gilead Sciences (GILD) Income Statement

13,844 Followers

Gilead Sciences Income Statement

Last quarter (Q4 2025), Gilead Sciences's total revenue was $7.92B, an increase of 4.70% from the same quarter last year. In Q4, Gilead Sciences's net income was $2.18B. See Gilead Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 29.44B$ 28.75B$ 27.12B$ 27.28B$ 27.30B
Gross Profit
$ 25.52B$ 22.50B$ 20.62B$ 21.62B$ 20.70B
Operating Expenses
$ 13.71B$ 20.84B$ 13.01B$ 14.29B$ 10.79B
Depreciation and Amortization
$ 0.00$ 2.77B$ 2.69B$ 2.10B$ 2.05B
EBITDA
$ 10.82B$ 4.43B$ 10.50B$ 8.85B$ 11.33B
Operating Income
$ 11.82B$ 1.66B$ 7.61B$ 7.33B$ 9.92B
Other Income/Expenses
$ -2.02B$ -972.00M$ -746.00M$ -1.52B$ -1.64B
Pretax Income
$ 9.80B$ 690.00M$ 6.86B$ 5.81B$ 8.28B
Net Income
$ 8.51B$ 480.00M$ 5.67B$ 4.59B$ 6.22B
Per Share Metrics
Basic EPS
$ 6.84$ 0.38$ 4.54$ 3.66$ 4.96
Diluted EPS
$ 6.78$ 0.38$ 4.50$ 3.64$ 4.93
Weighted Average Shares Outstanding
 1.24B 1.25B 1.25B 1.25B 1.26B
Weighted Average Shares Outstanding (Diluted)
 1.25B 1.25B 1.26B 1.26B 1.26B
Currency in USD

Gilead Sciences Earnings and Revenue History